[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fsRXtCJUwiTmAHcuZTFP2CAVUreabH50vjo7kl4E3haQ":8,"$fxcGkXJFFrLxJkhPbxi4EsKWDgrJTZnc_1U_c-fh7G5s":56,"$fJuJwrK4QrXIhlWBc4VYOO-qiqNj4kzcoq-P1CUEssh0":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},75611,867263,[],"https://ystcdn.venuertc.com/medical/ystApp/0YbWrtsGnIVSTzEaDbtlD7CaJRSwuqG9.png","李会敏","临清市人民医院","老年病内科","住院医师",384,0,"老年肺腺癌多药治疗及安全用药全攻略","","https://ystcdn.venuertc.com/venue/AI/c76026a6-bb39-462d-ac1b-b8c97f7cd996.jpg","\u003Cdiv class=\"drug-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-material-title\">老年肺腺癌多药治疗及安全用药全攻略\u003C/h1>\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg1\">\n    \u003Ch2 class=\"drug-material-section-title\">说到化疗和靶向药，安全细节你都掌握了吗？\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      其实，化疗、靶向治疗和免疫制剂在肺腺癌治疗中用途广泛，尤其在老年患者中，药品选择和管理必须非常仔细。本文将用7个要点，详细解析这些药物的成分、作用机制、用法用量、相互作用和不良反应管理，让你清楚了解，既避免风险又提升用药体验。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg2\">\n    \u003Ch2 class=\"drug-material-section-title\">01. 药品成分与剂型：怎么选？怎么用？\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      常见的肺腺癌治疗药物包括：\u003Cbr>\n      \u003Cb>• 培美曲塞\u003C/b>（Pemetrexed）：注射剂。\u003Cbr>\n      \u003Cb>• 多西他赛\u003C/b>（Docetaxel）：有溶液和冻干粉针，部分有白蛋白结合型，更适合耐受性差者。\u003Cbr>\n      \u003Cb>• 地舒单抗\u003C/b>（Denosumab）：皮下注射剂型，适合骨转移相关用药。\u003Cbr>\n      \u003Cb>• 免疫检查点抑制剂\u003C/b>（如帕博利珠单抗Pembrolizumab、纳武利尤单抗Nivolumab）：均为注射剂。\u003Cbr>\u003Cbr>\n      剂型的选择要严格遵医嘱。注射剂应用于医院，部分安全性高的制剂可居家皮下使用，但必须有专人培训后再操作。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg1\">\n    \u003Ch2 class=\"drug-material-section-title\">02. 作用机制：化疗、靶向与免疫剂各有巧妙\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cb>• 培美曲塞\u003C/b>：抑制肿瘤细胞DNA合成，减缓分裂增殖。\u003Cbr>\n      \u003Cb>• 多西他赛\u003C/b>：阻断细胞分裂时微管的正常功能，让异常细胞无法扩增。\u003Cbr>\n      \u003Cb>• 靶向药物\u003C/b>（如厄洛替尼Erlotinib、吉非替尼Gefitinib）：干预肿瘤信号转导，抑制生长通路。\u003Cbr>\n      \u003Cb>• 免疫检查点抑制剂\u003C/b>：解除对免疫细胞的刹车，帮助身体识别并清除异常细胞。\u003Cbr>\n      \u003Cb>• 地舒单抗\u003C/b>：阻断骨吸收过程，减缓骨转移引发的骨质流失。\u003Cbr>\n      这些药物分别从不同环节干扰肿瘤细胞行为，联用时效果常优于单用。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg2\">\n    \u003Ch2 class=\"drug-material-section-title\">03. 具体用法用量：时间、频率、周期不能错🕒\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cb>• 培美曲塞\u003C/b>：常2-3周/1次静脉输注，用前建议叶酸、维生素B12预防副作用。\u003Cbr>\n      \u003Cb>• 多西他赛（包括白蛋白结合型）\u003C/b>：1次/3周静脉注射，有时降低剂量以减少不良反应。\u003Cbr>\n      \u003Cb>• 地舒单抗\u003C/b>：皮下注射，每4周1次较常见，需同步补钙防止低钙血症。\u003Cbr>\n      \u003Cb>• 免疫检查点抑制剂\u003C/b>：按产品规定，通常每2-4周注射1次，细节见说明书。\u003Cbr>\n      正确做法：各药物固定间隔，严格遵医嘱；漏服或漏打，应第一时间咨询专科医生补救，绝不随意增量更改。\n    \u003C/p>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cspan class=\"drug-material-highlight\">使用案例：\u003C/span>\n      \"一位老年患者在地舒单抗治疗期间，因补钙不到位出现抽搐，后经医生指导加用钙剂症状缓解。\"\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg1\">\n    \u003Ch2 class=\"drug-material-section-title\">04. 用药过程中的特殊细节：你注意到了吗？👀\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cb>• 培美曲塞及多西他赛：\u003C/b>输注前后必须大量补液，预防肾脏损害。化疗期间建议避免服用非甾体抗炎药。\u003Cbr>\n      \u003Cb>• 地舒单抗：\u003C/b>用药前确认血钙水平，服药期间定期复查。\u003Cbr>\n      \u003Cb>• 靶向药：\u003C/b>部分药需空腹使用，如厄洛替尼，服药时间非常关键。\u003Cbr>\n      \u003Cb>• 免疫用药：\u003C/b>用前需排除活动性感染、控制肝肾功能。全程由医生监控。\u003Cbr>\n      \u003Cbr>\n      正确做法：严格遵守各自药品的特殊用药要求，有疑问时及时咨询药师或医生。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg2\">\n    \u003Ch2 class=\"drug-material-section-title\">05. 药物相互作用：老年人尤其要警惕⚡\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cb>• 培美曲塞\u003C/b>与阿司匹林、布洛芬同用，增加肾脏损伤概率。用药期间要避免使用这些常用止痛药。\u003Cbr>\n      \u003Cb>• 多西他赛\u003C/b>可与某些真菌药（如氟康唑）或抗结核药物（如利福平）发生相互作用，影响降解，需医师评估机制。\u003Cbr>\n      \u003Cb>• 靶向药\u003C/b>类（吉非替尼、奥希替尼等）与质子泵抑制剂（如奥美拉唑）联用时，有可能降低药效，应错开服用。\u003Cbr>\n      \u003Cb>• 免疫抑制剂\u003C/b>合并糖皮质激素、环孢素等，可能影响免疫应答和药效。\u003Cbr>\n      正确做法：专药专用，遇到新药加入，务必提前告知全体医生。\n    \u003C/p>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cspan class=\"drug-material-highlight\">临床数据：\u003C/span>一项回顾性研究显示，约8.5%的老年癌症患者因药物相互作用出现不良结果（Jin H, et al., 2021）。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg1\">\n    \u003Ch2 class=\"drug-material-section-title\">06. 不良反应及处理：常见、特殊、副作用要速识别！⚠\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cb>• 培美曲塞\u003C/b>：最常见为骨髓抑制（白细胞、血小板降低），反应明显时按规定暂停下次用药。恶心、口腔溃疡、毛发变细可能发生。\u003Cbr>\n      \u003Cb>• 多西他赛\u003C/b>：易引发脱发、下肢水肿，有时出现肝功异常。及时报告并按医嘱调整剂量。\u003Cbr>\n      \u003Cb>• 地舒单抗\u003C/b>：要注意下颌骨坏死风险，长期服用需注意口腔卫生。\u003Cbr>\n      \u003Cb>• 免疫检查点抑制剂\u003C/b>：部分人会有皮疹、乏力、关节痛，偶有严重过敏。\u003Cbr>\n      正确做法：出现皮疹、水肿、发热、长时间呕吐或出血，应停药并及时就医。常规不良反应多可逆转，但干预速度影响恢复质量。\n    \u003C/p>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cspan class=\"drug-material-highlight\">使用实例：\u003C/span>\n      \"临床上有患者在多西他赛期间出现明显水肿，减量后逐渐缓解。\"\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg2\">\n    \u003Ch2 class=\"drug-material-section-title\">07. 药品储存与手中剩余药物如何管理？📦\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      化疗、靶向及免疫药品都需要低温避光保存。\u003Cbr>\n      \u003Cb>正确做法：\u003C/b>\n      \u003C/p>\u003Cul class=\"drug-material-ul\">\n        \u003Cli>静脉注射药品仅限医疗机构保存与分发，不建议自带。\u003C/li>\n        \u003Cli>地舒单抗、部分生物制剂开封后冷藏储存，最长不超过7天。勿用超过有效期药品。\u003C/li>\n        \u003Cli>发现药液变色、瓶体有裂痕或沉淀，严禁使用。\u003C/li>\n      \u003C/ul>\n      \u003Cb>过量或漏服怎么办？\u003C/b>不要自行补打或加服，多咨询医生。出现剧烈反应如抽搐、晕厥，立即就医是唯一选择。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg1\">\n    \u003Ch2 class=\"drug-material-section-title\">08. 老年人特殊管理措施：安全性优先\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      老年患者多并用多种药物，代谢变慢，器官储备功能减弱——\u003Cspan class=\"drug-material-emoji\">🧓🏻\u003C/span> \n      \u003C/p>\u003Cul class=\"drug-material-ul\">\n        \u003Cli>化疗需起始低剂量，逐步调整。\u003C/li>\n        \u003Cli>特别易发生不良反应时，可优先选择副作用少的药品组合。\u003C/li>\n        \u003Cli>长期用药者务必定期复查肝肾功能、血象。\u003C/li>\n      \u003C/ul>\n      \u003Cb>正确做法：\u003C/b>每加用一种新药都要评估相互作用风险，重新衡量用药方案。\n    \u003Cp>\u003C/p>\n    \u003Cp class=\"drug-material-p\">\n      \u003Cspan class=\"drug-material-highlight\">病例精要：\u003C/span>一位高龄男性曾因化疗后不良反应严重，医生果断降低化疗剂量同时调整药物组合，后续不良反应明显减少，用药更持久。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg2\">\n    \u003Ch2 class=\"drug-material-section-title\">09. 总结：牢记2大关键，抗癌路更稳\u003C/h2>\n    \u003Cp class=\"drug-material-p\">\n      肺腺癌多药治疗副作用多，细节管理就是制胜法宝。务必遵医嘱，规范操作，每一次调整都需医生参与，全程定期监测，远离药品相互作用和储存误区，保护生命线更可靠！\n    \u003C/p>\n    \u003Cul class=\"drug-material-ul\">\n      \u003Cli>⏩ 所有化疗、靶向和免疫制剂都不得随意增减剂量或擅自停药。\u003C/li>\n      \u003Cli>⏩ 密切监控身体反应，异常及时反馈，绝不死扛。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drug-material-p\">\n      任何时候遇到用药难题，首选专业咨询，不要“自行其是”。合理用药，是老年患者安全抗癌的核心行动指南。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-material-section drug-material-section-bg1\">\n    \u003Ch2 class=\"drug-material-section-title\">参考文献\u003C/h2>\n    \u003Col class=\"drug-material-reference\">\n      \u003Cli>\n        Jin H, Wang X, Chen M, et al. Drug–drug interactions in elderly cancer patients: a review of the literature. \u003Cem>Cancer Chemotherapy and Pharmacology\u003C/em>. 2021;87(5):573-588. https://doi.org/10.1007/s00280-021-04270-8\n      \u003C/li>\n      \u003Cli>\n        Hanna N, Johnson D, Temin S, et al. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. \u003Cem>Journal of Clinical Oncology\u003C/em>. 2020;38(14):1608-1632. https://doi.org/10.1200/JCO.19.03088\n      \u003C/li>\n      \u003Cli>\n        Reck M, Remon J, Hellmann MD. First-line immunotherapy for non–small-cell lung cancer. \u003Cem>Journal of Clinical Oncology\u003C/em>. 2022;40(6):586-600. https://doi.org/10.1200/JCO.21.01783\n      \u003C/li>\n      \u003Cli>\n        Krug B, Bahl A, Oehl-Jaschkowitz B, et al. Denosumab for the Treatment of Bone Metastases in Patients With Solid Tumours. \u003Cem>European Journal of Cancer Care\u003C/em>. 2022;31(1):e13468. https://doi.org/10.1111/ecc.13468\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drug-material-container {\n  max-width: 840px;\n  margin: 40px auto 40px auto;\n  font-family: 'Helvetica Neue', Helvetica, Arial, 'Microsoft YaHei', sans-serif;\n  background: #f9fafa;\n  padding: 30px 38px;\n  border-radius: 16px;\n  box-shadow: 0 4px 22px rgba(80, 115, 180, 0.13);\n  line-height: 1.8;\n}\n.drug-material-title {\n  text-align: center;\n  font-size: 2.3em;\n  color: #265186;\n  font-weight: 700;\n  letter-spacing: .08em;\n  margin: 8px 0 28px 0;\n  padding-bottom: 18px;\n  border-bottom: 2px solid #e9f0f8;\n}\n.drug-material-section {\n  margin-bottom: 33px;\n  border-radius: 12px;\n  padding: 24px 24px 21px 24px;\n  box-shadow: 0 0 0 0 transparent;\n}\n.drug-material-section-bg1 {\n  background: linear-gradient(102deg, #f1f7fc 86%, #fafcff 99%);\n}\n.drug-material-section-bg2 {\n  background: linear-gradient(102deg, #f5f8f6 90%, #fbfbfd 100%);\n}\n.drug-material-section-title {\n  font-size: 1.45em;\n  color: #303e4e;\n  margin: 0 0 15px 0;\n  font-weight: 600;\n  border-left: 5px solid #b3bdda;\n  padding-left: 15px;\n  background-image: url(\"data:image/svg+xml,%3Csvg%20width%3D'67'%20height%3D'67'%20xmlns%3D'http%3A//www.w3.org/2000/svg'%3E%3Ccircle%20fill%3D'%23eaf5fb'%20cx%3D'33'%20cy%3D'33'%20r%3D'33'/%3E%3C/svg%3E\");\n  background-repeat: no-repeat;\n  background-size: 35px 35px;\n  background-position: right 5px top 5px;\n}\n.drug-material-p {\n  font-size: 1.06em;\n  margin-bottom: 0.83em;\n  color: #44556b;\n}\n.drug-material-highlight {\n  color: #7c305c;\n  font-weight: 600;\n  font-size: 1em;\n  background: #f9e5ed;\n  border-radius: 7px;\n  padding: 2px 7px;\n  margin-right: 7px;\n}\n.drug-material-ul {\n  margin: 11px 0 11px 2.6em;\n  padding-left: 1em;\n}\n.drug-material-ul li {\n  font-size: 1em;\n  color: #526075;\n  margin-bottom: 8px;\n}\n.drug-material-emoji {\n  font-size: 1.2em;\n  margin-left: 7px;\n  margin-right: 7px;\n}\n.drug-material-reference {\n  font-size: .97em;\n  padding-left: 1.4em;\n  color: #65748d;\n}\n.drug-material-reference li {\n  margin-bottom: 10px;\n  text-indent: -1.3em;\n  margin-left: 1.9em;\n  line-height: 1.65;\n}\n@media (max-width: 610px) {\n  .drug-material-container {\n    padding: 12px 10px;\n  }\n  .drug-material-section-title {\n    font-size: 1.11em;\n    padding-left: 9px;\n    background-size: 21px 21px;\n    background-position: right 3px top 3px;\n  }\n  .drug-material-section {\n    padding: 13px 10px 9px 11px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"drug-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-material-title\">老年肺腺癌多药治",522,"2025-12-06 03:13:32","肺癌四期腺癌常用药品实用药指南","肺癌, 四期腺癌, 抗肿瘤药物, 用药指南, 治疗, 不良反应, 靶向药, 免疫制剂","了解肺癌四期腺癌的有效用药指南，掌握关键用药细节，避免副作用，提高治疗效果，让每位患者都能安全用药，获得健康保障。","2025-12-15 16:44:06",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]